Clinical Trial Update: Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up [Phase 4]

View source ↗

Summary

Phase 4 follow-up study evaluating neurocognitive outcomes in the treatment of first-episode non-affective psychosis over 1 year.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Snippet

Sponsor: Fundación Marques de Valdecilla | Conditions: Schizophrenia, Psychotic Disorders | Phase 4 | Status: COMPLETED